Skip to content

CLIF Correction VS. Conventional Correction Strategy for ASD

A Novel Surgical Technique of CLIF Correction VS. Conventional Corrective Strategy on the Treatment of Adult Complex Spinal Deformity With a Multicenter Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05982808
Enrollment
420
Registered
2023-08-09
Start date
2024-07-01
Completion date
2028-06-01
Last updated
2023-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Deformity

Keywords

adult spinal deformity, CLIF, crenal lumbar interbody fusion, minimal invasive, correction, surgical strategy

Brief summary

The present study intends to: 1)establish a multi-center large-sample randomized controlled trial to explore the technical advantages and surgical indications of the novel surgical technique of CLIF correction for ASD compared with the conventional correction strategy; 2)analyze the postoperative clinical and imaging results, and to explore the related complications and preventive measures; 3) establish 2-year follow-up to further quantify the clinical and radiographical outcomes of CLIF correction.

Detailed description

Adult spinal deformity (ASD) is the most common spinal deformity in the elder, which often causes the low back pain and/or physical deformity. Severe cases need surgical treatment. Because the conventional posterior approach had the disadvantages of big trauma and slow recovery, and the elder were always complicated with complicated medical diseases, the perioperative risk was high. At present, the novel surgical technique of CLIF correction was a popular way for ASD treatment. Preliminary results showed that it had less trauma, shorter operation time, faster recovery, fewer complications and remarkable clinical and adiographical outcomes. Therefore, the present study intends to: 1) establish a multi-center large-sample randomized controlled trial to explore the technical advantages and surgical indications of the novel CLIF correction for ASD treatment compared with the conventional correction strategy; 2) establish 2-year follow-up to further quantify the clinical and radiographical outcomes, and to explore the related complications and preventive measures;. Therefore, the present project aims to explore the best surgical plan for treating ASD by studying the safety and effectiveness of the novel CLIF correction, and provide new surgical strategies for minimally invasive and Individualized treatment for ASD.

Interventions

PROCEDUREconventional correction strategy

conventional correction was the classic surgical techqiue of correction of spinal deformtiy with open posterior approach

PROCEDURECLIF correction

CLIF correction was a novel surgical techqiue of correction of spinal deformtiy with minimal invasive approach

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

with/without novel CLIF correction

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* adult spinal deformtiy; * 40yrs≤age≤80yrs; * Lenke-Silva classification II-V grade; * ineffective with conservative treatment;

Exclusion criteria

* severe osteoprosis with T value \<-2.5; * with preliminary spinal surgery; * ASA score≥III grade; * more than II degree spondylisthesis; * with mental disease;

Design outcomes

Primary

MeasureTime frameDescription
ODI score2 year after surgeryODI score is Oswestry Disability Index(0-100), indicating the back pain; the higher score, the greater back pain

Secondary

MeasureTime frameDescription
SF-36 score2 year after surgerySF-36 score is the MOS item short from health survey (0-100), indicating the life quality; the higher score, the better life quality

Countries

China

Contacts

Primary ContactZhi-wei WANG, Ph.D and MD.
2316002@zju.edu.cn0571-88981080
Backup ContactFang-cai LI, Ph.D and MD.
2505004@zju.edu.cn0571-88981080

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026